10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vascular dysfunction predisposes to cardiovascular complications of metabolic syndrome (MetS). The current study investigated the mechanism(s) of curcumin’s (CUR) protective effect against vascular reactivity irregularities in MetS. MetS was induced by feeding rats on high fructose high salt diet. Tension studies were undertaken in aortic rings to assess the influence of CUR on vasoconstrictor or vasorelaxant responses. The effect on advanced glycation endproducts (AGEs) was studied by incubating aortic tissues with methylglyoxal, the AGEs precursor, in the absence and presence of CUR. In addition, CUR effects on in-vitro generation of AGEs and diphenyl-2-picrylhydrazyl (DPPH) free radicals were studied. The incubation with CUR for 1 hr produced significant and concentration-dependent alleviation of the exaggerated vasoconstriction observed in aortas isolated from MetS, however failed to improve the concomitant attenuation of vasodilatory responses to ACh in PE-precontracted aortas. By contrast, CUR caused direct concentration-dependent vasodilations of precontracted aortas, effects that were blunted after nitric oxide synthase inhibition by L-NAME. Similar to its effects in MetS aortas, CUR alleviated exaggerated PE vasoconstriction but did not affect impaired ACh vasodilations in AGEs-exposed aortas. In addition, CUR showed significant dose-dependent DPPH free radicals scavenging activity and inhibited both MG and fructose induced AGEs formation at the level of protein oxidation step as evident from the effect on dityrosine and N-formylkyramine. CUR alleviates exaggerated vasoconstriction in MetS through interfering with AGEs formation and AGEs-induced vascular injury. Free radical scavenging and direct vasodilatory activities could also participate in the advantageous vascular actions of CUR.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Curcumin: the story so far.

          Curcumin is a polyphenol derived from the herbal remedy and dietary spice turmeric. It possesses diverse anti-inflammatory and anti-cancer properties following oral or topical administration. Apart from curcumin's potent antioxidant capacity at neutral and acidic pH, its mechanisms of action include inhibition of several cell signalling pathways at multiple levels, effects on cellular enzymes such as cyclooxygenase and glutathione S-transferases, immuno-modulation and effects on angiogenesis and cell-cell adhesion. Curcumin's ability to affect gene transcription and to induce apoptosis in preclinical models is likely to be of particular relevance to cancer chemoprevention and chemotherapy in patients. Although curcumin's low systemic bioavailability following oral dosing may limit access of sufficient concentrations for pharmacological effect in certain tissues, the attainment of biologically active levels in the gastrointestinal tract has been demonstrated in animals and humans. Sufficient data currently exist to advocate phase II clinical evaluation of oral curcumin in patients with invasive malignancy or pre-invasive lesions of the gastrointestinal tract, particularly the colon and rectum.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Noninvasive assessment of arterial stiffness and risk of atherosclerotic events.

            Investigation of arterial stiffness, especially of the large arteries, has gathered pace in recent years with the development of readily available noninvasive assessment techniques. These include the measurement of pulse wave velocity, the use of ultrasound to relate the change in diameter or area of an artery to distending pressure, and analysis of arterial waveforms obtained by applanation tonometry. Here, we describe each of these techniques and their limitations and discuss how the measured parameters relate to established cardiovascular risk factors and clinical outcome. We also consider which techniques might be most appropriate for wider clinical application. Finally, the effects of current and future cardiovascular drugs on arterial stiffness are also discussed, as is the relationship between arterial elasticity and endothelial function.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Understanding the pathogenesis of abdominal aortic aneurysms.

              An aortic aneurysm is a dilatation in which the aortic diameter is ≥3.0 cm. If left untreated, the aortic wall continues to weaken and becomes unable to withstand the forces of the luminal blood pressure resulting in progressive dilatation and rupture, a catastrophic event associated with a mortality of 50-80%. Smoking and positive family history are important risk factors for the development of abdominal aortic aneurysms (AAA). Several genetic risk factors have also been identified. On the histological level, visible hallmarks of AAA pathogenesis include inflammation, smooth muscle cell apoptosis, extracellular matrix degradation and oxidative stress. We expect that large genetic, genomic, epigenetic, proteomic and metabolomic studies will be undertaken by international consortia to identify additional risk factors and biomarkers, and to enhance our understanding of the pathobiology of AAA. Collaboration between different research groups will be important in overcoming the challenges to develop pharmacological treatments for AAA.
                Bookmark

                Author and article information

                Contributors
                oaahmed@kau.edu.sa
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                15 January 2020
                15 January 2020
                2020
                : 10
                : 315
                Affiliations
                [1 ]ISNI 0000 0001 0619 1117, GRID grid.412125.1, Department of Pharmaceutics, Faculty of Pharmacy, , King Abdulaziz University, ; Jeddah, KSA Saudi Arabia
                [2 ]ISNI 0000 0000 8999 4945, GRID grid.411806.a, Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, , Minia University, ; Minia, Egypt
                [3 ]ISNI 0000 0001 2158 2757, GRID grid.31451.32, Department of Pharmacology and Toxicology, Faculty of Pharmacy, , Zagazig University, ; Zagazig, Egypt
                [4 ]ISNI 0000 0001 0619 1117, GRID grid.412125.1, Pediatric Cardiac Center of Excellence, Faculty of Medicine, , King Abdulaziz University, ; Jeddah, KSA Saudi Arabia
                [5 ]ISNI 0000 0001 0619 1117, GRID grid.412125.1, Department of Biochemistry, Faculty of Science, , King Abdulaziz University, ; Jeddah, KSA Saudi Arabia
                [6 ]ISNI 0000 0001 2260 6941, GRID grid.7155.6, Department of Pharmacology and Toxicology, Faculty of Pharmacy, , Alexandria University, ; Alexandria, Egypt
                Author information
                http://orcid.org/0000-0002-3204-381X
                http://orcid.org/0000-0001-8855-7070
                Article
                57268
                10.1038/s41598-019-57268-z
                6962217
                31941978
                f6d97b92-acac-4b79-9c74-35ac429fe8fd
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 26 September 2019
                : 23 December 2019
                Funding
                Funded by: This work was supported by the National Science, Technology and Innovation Plan (NSTIP) strategic technologies program in the Kingdom of Saudi Arabia, Project No. 14-BIO929-03.
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                pharmacology,metabolic syndrome
                Uncategorized
                pharmacology, metabolic syndrome

                Comments

                Comment on this article